SCICLONE PHARMACEUTICALS INC Retained Earnings
SCICLONE PHARMACEUTICALS INC had Retained Earnings of -$61.12 million as of 2017-06-30, per its 10-Q filed 2017-08-09.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2017-08-09
- 2017-06-30: Retained Earnings (Accumulated Deficit) -$61.12M.
- 2017-03-31: Retained Earnings (Accumulated Deficit) -$73.30M.
- 2016-12-31: Retained Earnings (Accumulated Deficit) -$87.77M.
- 2016-09-30: Retained Earnings (Accumulated Deficit) -$94.18M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2017-06-30 | -$61.12M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | -$73.30M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | -$87.77M 10-Q · filed 2017-08-09 | |
| 2016-09-30 | -$94.18M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | -$104.29M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | -$110.63M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | -$118.49M 10-K · filed 2017-03-09 | |
| 2015-09-30 | -$131.04M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | -$135.46M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | -$128.94M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | -$135.15M 10-K · filed 2016-03-11 | |
| 2014-09-30 | -$128.80M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | -$130.78M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | -$134.40M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | -$135.96M 10-K · filed 2015-03-12 | |
| 2013-09-30 | -$133.32M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | -$134.69M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | -$132.70M 10-Q · filed 2013-08-09 | |
| 2012-12-31 | -$134.41M 10-K · filed 2014-03-17 | |
| 2012-09-30 | -$129.93M 10-Q/A · filed 2013-04-01 | -$131.56M 10-Q · filed 2012-11-09 |
| 2012-06-30 | -$107.20M 10-Q/A · filed 2013-04-01 | -$108.45M 10-Q · filed 2012-08-08 |
| 2012-03-31 | -$110.65M 10-Q/A · filed 2013-04-01 | -$111.29M 10-Q · filed 2012-05-10 |
| 2011-12-31 | -$119.20M 10-Q/A · filed 2013-04-01 | -$118.85M 10-K · filed 2012-03-15 |
| 2011-09-30 | -$127.76M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | -$137.99M 10-Q · filed 2011-08-09 | |
| 2010-12-31 | -$143.82M 10-K · filed 2012-03-15 |